News
Ardelyx, Inc. (ARDX) Stock on a Gaining Trajectory, Here’s the Reason
Ardelyx, Inc., a biopharmaceutical company, closed Monday’s regular session at $1.17 after surging 9.35% during the day. In the premarket
Menu
Ardelyx, Inc., a biopharmaceutical company, closed Monday’s regular session at $1.17 after surging 9.35% during the day. In the premarket